Abstract

Currently three bona fide dendritic cell (DC) types are distinguished in human blood. Herein we focus on type 2 DCs (DC2s) and compare the three defining markers CD1c, CD172, and CD301. When using CD1c to define DC2s, a CD14+ and a CD14− subset can be detected. The CD14+ subset shares features with monocytes, and this includes substantially higher expression levels for CD64, CD115, CD163, and S100A8/9. We review the current knowledge of these CD1c+CD14+ cells as compared to the CD1c+CD14− cells with respect to phenotype, function, transcriptomics, and ontogeny. Here, we discuss informative mutations, which suggest that two populations have different developmental requirements. In addition, we cover subsets of CD11c+CD8− DC2s in the mouse, where CLEC12A+ESAMlow cells, as compared to the CLEC12A−ESAMhigh subset, also express higher levels of monocyte-associated markers CD14, CD3, and CD115. Finally, we summarize, for both man and mouse, the data on lower antigen presentation and higher cytokine production in the monocyte-marker expressing DC2 subset, which demonstrate that the DC2 subsets are also functionally distinct.

Highlights

  • In human blood, cells with dendritic cell (DC) properties have been classified as plasmacytoid DCs, as CD141+ DCs and as CD1c+ DCs [1,2,3]

  • In order to appropriately address the question of lineage assignment of the subsets of CD1c+ DCs, approaches using a broad panel of different monocytes, macrophages, and dendritic cells are required

  • When looking at IRF8 CRISPR/Cas9 knock-out mutation in human in vitro induced pluripotent stem cells, it was noted that the generation of plasmacytoid DCs (pDCs) and DC1 cells driven by FLT3L, SCF, GM-CSF, and IL-4 (FSG4) was ablated but the generation of CD1c+ DC2s was unaffected [69]

Read more

Summary

Introduction

Cells with dendritic cell (DC) properties have been classified as plasmacytoid DCs (pDCs), as CD141+ DCs and as CD1c+ DCs [1,2,3]. Among the CD1c+ DCs there is higher expression for several monocyte-associated genes (CD14, CD115, MAFB, S100A8/9, CD163, and Ficolin1) in cells defined either as CD14+ cells or as CD5−. In order to appropriately address the question of lineage assignment of the subsets of CD1c+ DCs, approaches using a broad panel of different monocytes, macrophages, and dendritic cells are required.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call